Dorottya Csuka Selected Research

Danazol (Azol)

2/2016	The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.
12/2014	Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema.
3/2011	Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?
3/2011	Long-term efficacy of danazol treatment in hereditary angioedema.
4/2010	The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dorottya Csuka Research Topics

Disease

31	Hereditary Angioedemas 03/2022 - 03/2010
8	Angioedema 01/2022 - 10/2011
6	Thrombotic Microangiopathies 01/2022 - 01/2017
6	Atypical Hemolytic Uremic Syndrome 01/2021 - 06/2015
6	Infections 01/2021 - 07/2013
5	Thrombotic Thrombocytopenic Purpura 01/2019 - 04/2014
4	Neoplasms (Cancer) 03/2022 - 04/2010
3	COVID-19 02/2022 - 01/2021
3	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2021 - 11/2019
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2022 - 11/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 11/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 06/2015
2	Inflammation (Inflammations) 01/2021 - 02/2012
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2017
2	Hemolytic-Uremic Syndrome 01/2019 - 01/2016
2	Sepsis (Septicemia) 01/2019 - 01/2017
2	Pre-Eclampsia (Preeclampsia) 01/2018 - 12/2010
2	Edema (Dropsy) 12/2015 - 01/2013
2	Thrombocytopenia (Thrombopenia) 06/2015 - 11/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2012 - 10/2011
1	Malignant Hypertension 03/2022
1	Hereditary Complement Deficiency Diseases 01/2022
1	Rare Diseases (Rare Disease) 11/2021
1	Transthyretin-Related Hereditary Amyloidosis 01/2021
1	Acquired angioedema 01/2021
1	Ischemic Stroke 08/2020
1	Stroke (Strokes) 08/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Disseminated Intravascular Coagulation 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Hemorrhage 01/2018
1	HELLP Syndrome 01/2018
1	Convalescence 01/2017
1	Glomerulonephritis 01/2017

Drug/Important Bio-Agent (IBA)

30	Complement System Proteins (Complement)IBA 02/2022 - 03/2010
8	BradykininIBA 12/2021 - 02/2012
5	Danazol (Azol)FDA LinkGeneric 02/2016 - 04/2010
4	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 08/2018
4	AntibodiesIBA 01/2022 - 01/2011
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2013
4	Complement Factor H (Factor H)IBA 01/2021 - 06/2015
4	LectinsIBA 08/2020 - 12/2014
4	thiamine triphosphorate (TTP)IBA 01/2019 - 04/2014
3	von Willebrand FactorIBA 02/2022 - 02/2012
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2021 - 11/2019
3	C-Reactive ProteinIBA 01/2021 - 02/2012
3	EnzymesIBA 01/2021 - 12/2014
3	Pharmaceutical PreparationsIBA 01/2019 - 04/2010
3	AutoantibodiesIBA 01/2017 - 01/2011
3	Leukocyte Elastase (Neutrophil Elastase)IBA 05/2016 - 04/2014
3	Immunoglobulin G (IgG)IBA 07/2013 - 03/2011
2	CollagenIBA 02/2022 - 02/2012
2	FicolinsIBA 08/2020 - 07/2013
2	Arginine (L-Arginine)FDA Link 08/2020 - 01/2017
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 08/2020 - 12/2010
2	eculizumab FDA Link 01/2019 - 11/2014
2	Endothelin-1 (Endothelin 1)IBA 02/2016 - 02/2012
2	AndrogensIBA 12/2014 - 03/2011
2	Immunoglobulin A (IgA)IBA 11/2014 - 03/2011
2	Immunoglobulin M (IgM)IBA 10/2011 - 01/2011
1	AntigensIBA 02/2022
1	ThrombospondinsIBA 02/2022
1	DisintegrinsIBA 02/2022
1	Metalloproteases (Metalloproteinases)IBA 02/2022
1	Factor XII (Hageman Factor)IBA 11/2021
1	PlasminogenIBA 11/2021
1	Glucosamine (Dona)IBA 11/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2021
1	Angiopoietin-1IBA 11/2021
1	ImmunosorbentsIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Prealbumin (Transthyretin)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 01/2021
1	Plasma KallikreinIBA 01/2021
1	symmetric dimethylarginineIBA 08/2020
1	complement 4 nephritic factorIBA 11/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	N 30IBA 01/2019
1	Kininogens (Kininogen)IBA 12/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2017
1	Biological ProductsIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	EpitopesIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017

Therapy/Procedure

10	Therapeutics 03/2022 - 03/2011
2	Percutaneous Coronary Intervention 12/2016 - 05/2013
2	Aftercare (After-Treatment) 02/2016 - 12/2012
1	Lung Transplantation 03/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Length of Stay 01/2021
1	Kidney Transplantation 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Curettage 01/2018
1	Stem Cell Transplantation 01/2018